Changes in Long-term Care Pharmacy Practice

NOVEMBER 18, 2011
CMS is proposing a change in long-term care pharmacy practice. By January 2013, consulting pharmacy must be separated from the company that supplies the drugs. I wonder why this separation is being proposed.

If this change is implemented, would it be advancement for pharmacy in general and consulting pharmacy in particular? Is this further evidence that the drug product has become a commodity business? If CMS mandates this in nursing homes pharmacy practice, could it follow that medication therapy management activities would have to be performed by an entity separated from the company that supplies the drug products in the community or mail order setting too?

This does sound like an opportunity for a new pharmacy business model that could meet both nursing home and community pharmacy needs. Does this look like a new opportunity to you, too?


Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?

Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.